⌘K
Loading ticker…
CareDx, Inc. · Healthcare · Healthcare
As of 2026-06-26, CareDx, Inc. (CDNA) has a 3-month relative strength percentile of 93 and a leadership percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 69. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.6%, relative volume 1.73×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 93, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
CDNA is in a stage 2 uptrend, week 9. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 28.9% / 54.3%.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
CDNA is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $27M notional. Top 3 carry $74M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $27M |
| XBIState Street SPDR S&P Biotech ETF | 0.35% | $26M |
| IWMiShares Russell 2000 ETF | 0.03% | $21M |
| VXFVanguard Extended Market ETF | 0.01% | $10M |
| IWOiShares Russell 2000 Growth ETF | 0.06% | $7M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CDNA Jan avg: 5.04% median: 8.95% win: 75% σ: 24.75% n: 4 2022-04-12 → 2026-05-29 | CDNA Feb avg: 5.81% median: 3.82% win: 50% σ: 15.43% n: 4 2022-04-12 → 2026-05-29 | CDNA Mar avg: -18.36% median: -13.66% win: 0% σ: 19.89% n: 4 2022-04-12 → 2026-05-29 | CDNA Apr avg: -7.90% median: -11.49% win: 20% σ: 17.45% n: 5 2022-04-12 → 2026-05-29 | CDNA May avg: 11.85% median: 0.65% win: 60% σ: 32.68% n: 5 2022-04-12 → 2026-05-29 | CDNA Jun avg: 6.58% median: 10.76% win: 75% σ: 15.09% n: 4 2022-04-12 → 2026-05-29 (current) | CDNA Jul avg: 7.67% median: 19.55% win: 75% σ: 31.02% n: 4 2022-04-12 → 2026-05-29 | CDNA Aug avg: 8.15% median: -1.74% win: 50% σ: 33.03% n: 4 2022-04-12 → 2026-05-29 | CDNA Sep avg: -7.47% median: -5.75% win: 50% σ: 14.24% n: 4 2022-04-12 → 2026-05-29 | CDNA Oct avg: -7.92% median: -9.78% win: 50% σ: 21.69% n: 4 2022-04-12 → 2026-05-29 | CDNA Nov avg: 18.64% median: 15.01% win: 75% σ: 47.03% n: 4 2022-04-12 → 2026-05-29 | CDNA Dec avg: 1.09% median: -3.23% win: 50% σ: 17.18% n: 4 2022-04-12 → 2026-05-29 |